The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland

ABSTRACT

Background: The appropriate access to public information is very important for healthcare system stakeholders. The goal of this study was to examine how the execution of the formally existing right to public information on the HTA-based recommendations on reimbursement of new health technologies from public funds has been changing in Poland.

Methods: All recommendations published within two predefined equal periods of time between 2013 and 2015 were analyzed. The gathered data was subjected to statistical analysis.

Results: The frequency and intensity of censoring the published HTA-based recommendations on the pharmaceutical reimbursement has diminished. The text readability and clarity of message has improved, although the degree of decisiveness of the recommendations has dropped.

Conclusion: The positive changes in the public communication policy should be continued. The transparency of the HTA-based recommendations should be increased further in some areas in the future.

KEYWORDS:

• Health technology assessment
• HTA
• pharmaceutical reimbursement
• public information
• citizens’ rights
• transparency
• Poland

Acknowledgment

The Authors of the present study would like to express their gratitude to Ms. Joanna Blonska for her participation in the gathering of the data.

Declaration of interest

Some of the Authors are employed by health authorities or organizations involved in health technology assessment. However, the content of this paper, as well as the views and opinions expressed therein are those of the Authors and not the organizations that employ them. The paper has been based on the publicly available information.

Additional information

Funding

This manuscript received no funding; however, the write-up was in part supported by the Jagiellonian University in Krakow, Poland.